A D Grant
Overview
Explore the profile of A D Grant including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
130
Citations
1296
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Walker N, Karim F, Moosa M, Moodley S, Mazibuko M, Khan K, et al.
J Infect Dis
. 2022 May;
226(5):928-932.
PMID: 35510939
Current methods for tuberculosis treatment monitoring are suboptimal. We evaluated plasma matrix metalloproteinase (MMP) and procollagen III N-terminal propeptide concentrations before and during tuberculosis treatment as biomarkers. Plasma MMP-1, MMP-8,...
2.
Fentress M, Henwood P, Maharaj P, Mitha M, Khan D, Jackpersad R, et al.
Public Health Action
. 2022 Mar;
12(1):3-6.
PMID: 35317533
Thoracic ultrasound is an appealing alternative to chest radiography for the diagnosis of TB. Based on research experience conducting thoracic ultrasound for adults and children in South Africa, three key...
3.
Mitrani L, Dickson-Hall L, Le Roux S, Hill J, Loveday M, Grant A, et al.
Public Health Action
. 2021 Sep;
11(3):120-125.
PMID: 34567987
Objective: To describe the medical, socio-economic and geographical profiles of patients with rifampicin-resistant TB (RR-TB) and the implications for the provision of patient-centred care. Setting: Thirteen districts across three South...
4.
McCreesh N, Grant A, Yates T, Karat A, White R
Int J Tuberc Lung Dis
. 2020 Apr;
24(4):403-408.
PMID: 32317064
In South Africa, it is generally estimated that only 0.5-0.6% of people's contacts occur in clinics. Both people with infectious tuberculosis and people with increased susceptibility to disease progression may...
5.
Karat A, Omar T, Tlali M, Charalambous S, Chihota V, Churchyard G, et al.
Public Health Action
. 2020 Feb;
9(4):186-190.
PMID: 32042614
Current estimates of the burden of tuberculosis (TB) disease and cause-specific mortality in human immunodeficiency virus (HIV) positive people rely heavily on indirect methods that are less reliable for ascertaining...
6.
Hill J, Dickson-Hall L, Grant A, Grundy C, Black J, Kielmann K, et al.
Int J Tuberc Lung Dis
. 2020 Feb;
24(1):83-91.
PMID: 32005310
Thirteen districts in Eastern Cape (EC), KwaZulu-Natal (KZN) and Western Cape (WC) Provinces, South Africa. To pilot a methodology for describing and visualising healthcare journeys among drug-resistant tuberculosis (DR-TB) patients...
7.
Hanifa Y, Toro Silva S, Karstaedt A, Sahid F, Charalambous S, Chihota V, et al.
Int J Tuberc Lung Dis
. 2019 Jan;
23(2):157-165.
PMID: 30678747
Objective: To identify the causes of symptoms suggestive of tuberculosis (TB) among people living with the human immunodeficiency virus (PLHIV) in South Africa. Methods: A consecutive sample of HIV clinic...
8.
Mukora R, Tlali M, Monkwe S, Charalambous S, Karat A, Fielding K, et al.
Int J Tuberc Lung Dis
. 2018 Aug;
22(9):1082-1087.
PMID: 30092876
Introduction: The World Health Organization recommends point-of-care (POC) lateral flow urine lipoarabinomannan (LF-LAM) for tuberculosis (TB) diagnosis in selected human immunodeficiency virus (HIV) positive people. South Africa had 438 000...
9.
Kufa T, Fielding K, Hippner P, Kielmann K, Vassall A, Churchyard G, et al.
Contemp Clin Trials
. 2018 Jul;
72:43-52.
PMID: 30053431
Objectives: To evaluate the effect of an intervention to optimize TB/HIV integration on patient outcomes. Methods: Cluster randomised control trial at 18 primary care clinics in South Africa. The intervention...
10.
Smith C, Lessells R, Grant A, Herbst K, Tanser F
Int J Tuberc Lung Dis
. 2018 Feb;
22(3):287-293.
PMID: 29471906
Setting: Incidencerates of tuberculosis (TB) in South Africa are among the highest in the world, and drug resistance is a major concern. Understanding geographic variations in disease may guide targeted...